Perception of vitiligo patients about their illness: A single center study in Egypt
Illness perception of vitiligo patients
DOI:
https://doi.org/10.66344/jpad.v31i4.1749Abstract
Objective This study aims to describe the illness perception of vitiligo patients and its associated factors.
Methods In this cross-sectional study, the Arabic version of illness perception questionnaire was completed from 100 vitiligo patients. Patients were asked about their beliefs of the cause of vitiligo. The median score of the seven subscales (acute/chronic, cyclical, consequences, personal control, treatment control, disease understanding and emotional effects) were calculated and their variations with different parameters were compared.
Results Majority of patients believe that emotional state, family problems, altered immunity, heredity and infections are causes of vitiligo. The median scores of beliefs about chronicity, cyclical nature, consequences, personal control, treatment control, disease understanding and emotional effects are 18, 12, 17, 21, 18, 14 and 24; respectively. The median scores of beliefs about chronicity and cyclical nature are significantly higher among patients with above secondary education and in patients with more than 36 months of disease duration. The median scores of beliefs about disease understanding is significantly higher among patients of younger age; unmarried and with younger age of onset.
Conclusion Patients have wrong beliefs about causes of vitiligo and believe that their life and emotions are strongly influenced by the disease. Health education and psychological counseling could correct these beliefs and influences.
References
1. Mohammed GF, Gomaa AH, Al-Dhubaibi MS. Highlights in pathogenesis of vitiligo. World J of clinical cases.2015;3(3):221–30.
2. Halder RM, Chappell JL. Vitiligo update. Seminars Cutan Med Surg.2009;28(2):86–92.
3. Al-Ghamdi KM. Beliefs and perceptions of Arab vitiligo patients regarding their condition. Int J Dermatol.2010;49:1141–5.
4. Al-Ghamdi KM, Moussa NA, Mandel A, AlKofida M, Madani A, AlDaham N, et al. Public perceptions and attitudes towards vitiligo. J Cutan Med Surg.2012;16(5):334-40.
5. Al-Robaee AA, Al-Zolibani A, Al-Shobaili A. Knowledge and attitude towards vitiligo in Qassim Locality, Saudi Arabia. J Pak Assoc Dermatol.2008;18(2):78-83.
6. Diefenbach MA. Illness representation.2011. Retrieved from http://cancercontrol.cancer.gov/brp/constructs/illness_representations/illness_representations.pdf. [Accessed at “September, 28, 2019”].
7. Papadopoulos L, Bor R, Walker C, Legg C. The Illness Perception Questionnaire as a reliable assessment tool: Cognitive representations of vitiligo. Psychol Health Med.2001;6(4):441-6.
8. Papadopoulos L, Bor R, Walker C, Flaxman P, Legg C. Different shades of meaning: illness beliefs among vitiligo sufferers. Psychol Health Med. 2002;7(4): 425-433.
9. Rossiter ND, Chapman P, Haywood IA. How big is a hand? Burns.1996;22(3):230-1.
10. Kim DY, Lee JW, Whang SH, Park YK, Hann SK, Shin YJ. Quality of life for Korean patients with vitiligo: Skindex‐29 and its correlation with clinical profiles. J Dermatol.2009;36(6):317-22.
11. Moss-Morris R, Weinman J, Petrie KJ, Horne R, Cameron LD, Buick D. The revised Illness Perception Questionnaire. Psychol Health.2002;17(1):1-16.
12. Firooz A, Bouzari N, Fallah N, Ghazisaidi B, Firoozabadi MR, Dowlati Y. What patients with vitiligo believe about their condition? Int J Dermatol.2004;43(11):811- 4.
13. Aflakseir A. Role of illness and medication perceptions on adherence to medication in a group of Iranian patients with type 2 diabetes. J Diabetes.2012;4(3): 243-7.
14. Halder RM, Taliaferro SJ. Vitiligo. In Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS & Leffell DJ. (Eds.). Fitzpatrick’s Dermatology in General Medicine; 2008 pp. 616-22. McGraw-Hill, New York.
15. Broadbent E, Wilkes C, Koschwanez H, Weinman J, Norton S, Petrie K. A systematic review and meta-analysis of the brief illness perception questionnaire. Psychol Health.2015;30:1361–85.
16. Bonsaksen T, Lerdal A, Fagermoen MS. Trajectories of illness perceptions in persons with chronic illness: An explorative longitudinal study. J Health Psychol.2015;20:942-53.
17. Topal IO, Duman H, Goncu OE, Durmuscan M, Gungor S, Ulkumen PK. Knowledge, beliefs, and perceptions of Turkish vitiligo patients regarding their condition. Anais Brasileiros De Dermatologia. 2016; 91(6):770–5.
18. Agrawal S, Kumar A, Shyngwa PM. Understanding of Nepalese patients with vitiligo about their disease. Nepal J Dermatol Venereol Leprol.2014;12(1):7-13.
19. Borimnejad L, Parsa Yekta Z, Nikbakht-Nasrabadi A, Firooz A. Quality of life with vitiligo: comparison of male and female Muslim patients in Iran. Gender Med.2006;3(2):124-30.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Abdel-Hady El-Gilany, Abeer Mahfouz , Moheiddin El-Ghobary, Hassan Fayed
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
